Medications listed here may also be marketed under different names in different countries. Mylan markets products in more than 165 countries and territories. Mylan Laboratories Inc. is a leading pharmaceutical company with four subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., UDL Laboratories, Inc. and Bertek Pharmaceuticals Inc., that develop, manufacture and market an extensive line of generic and proprietary products. verapamil.
ISOPTIN. Access the latest company news regarding Mylan’s commitment to public health amid the evolving COVID-19 pandemic. Over the past few years, Mylan has organized its products and services into 10 major therapeutic areas, helping us better focus on patients' needs by providing prescription generic, branded generic and brand-name drugs and OTC remedies where they are needed most. * Net revenues increased 8% to a record $1.37 billion. Mylan offers a varied portfolio of consumer health products including over-the-counter (OTC) medicines, cosmetics and nutritional supplements. 2.6 Angina 2.5 Arrhythmias 2.2 Hypertension - CCB, beta-blockers, others. Produkte Wir verfügen über ein Portfolio an verschreibungspflichtigen Arzneimitteln in den Therapiebereichen Gastroenterologie, Herz-Kreislauf-Erkrankungen, Frauengesundheit, ZNS/Schmerz, Dermatologie und Atemwege. For more information about Mylan, visit www.mylan.com .
Mylan’s commitment to allow expanded patient access to treatment throughout the entire world is shown in … Always read the leaflet and/or label prior to use. Mylan ist stolz mit dem Globalen Fonds zur Bekämpfung von AIDS, Tuberkulose und Malaria zusammenzuarbeiten The global company ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in approximately 150 countries and territories.
Through the ongoing provision of our branded products and services to support specialty care, General Practice, pharmacy and consumers, we are dedicated to setting new standards in healthcare and providing the world's 7 billion people access to high quality medicine. Mylan Teoranta Mylan Pharmaceuticals Inc. PHARMACEUTICALS NON HAZ HYDRALAZINE, KETAMINE, AMIODARONE & NALOXONE STC 582 CARTONS PACKED ON 16 PALLETS INV # 30036, 30037, 30034, 30038, 30035 TEMP SET 22. Mylan’s operations in Ireland include Gerard Laboratories and Bioniche Pharma. Non-US country and region specific information is not available on this page. OTC Treatment Areas.
Mylan IRE Healthcare Ltd, Newenham Court, Northern Cross, Malahide Road, Dublin 17 ... 9.1 Vaccines and immunoglobulin products.
The Investor Relations website contains information about Mylan N.V.'s business for stockholders, potential investors, and financial analysts.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing 7 billion people access to high quality medicine. Zum Jahresende 2016 beschäftigte Mylan weltweit knapp 35.000 Mitarbeiter und erzielte im Geschäftsjahr 2016 einen Umsatz von 11,1 Milliarden US-Dollar.
Mylan's operations in Ireland include Gerard Laboratories and Bioniche Pharma. Drugs Associated with Mylan Pharmaceuticals Inc. Mylan Pharmaceuticals Inc. manufactures, markets and/or distributes more than 387 drugs in the United States. Learn how Mylan grew tremendously from humble beginnings in rural West Virginia to marketing more than 7,500 products worldwide today.
This structure helps us look at healthcare holistically and challenges us to provide access throughout patients' lives. We manufacture and market more than 1,200 different medicines to retail, wholesale, government and institutional customers. Mylan in Malaysia We back our commitment to helping provide 7 billion people access to high-quality medicine with an industry-leading and continually expanding portfolio. Mylan ist ein niederländisches Arzneimittelunternehmen mit Hauptsitz in Amsterdam, operativer Hauptzentrale in Hatfield im Vereinigten Königreich und deutschem Sitz in Bad Homburg. Our Commercial Offerings in India.
Our customers include consumers, retail and pharmacy establishments, wholesalers, governments, institutions and physicians. 0 C HS-CODE 30049000
Mylan’s many years of experience and ability to develop, manufacture, and successfully market complex products globally has made Mylan a leading global provider of biosimilars. 1981: Mylan helps found the Generic Pharmaceutical Industry Association.The group lobbies for the Hatch-Waxman Act—a response to the high price of brand name drugs.